| Literature DB >> 29256599 |
Eric Goffin1, Thomas Drapier1, Anja Probst Larsen2, Pierre Geubelle1,3, Christopher P Ptak4, Saara Laulumaa2, Karoline Rovinskaja2, Julie Gilissen1,3, Pascal de Tullio1, Lars Olsen2, Karla Frydenvang2, Bernard Pirotte1, Julien Hanson1,3, Robert E Oswald4, Jette Sandholm Kastrup2, Pierre Francotte1.
Abstract
We report here the synthesis of 7-phenoxy-substituted 3,4-dihydro-2H-1,2,4-benzothiadiazine 1,1-dioxides and their evaluation as AMPA receptor positive allosteric modulators (AMPApams). The impact of substitution on the phenoxy ring and on the nitrogen atom at the 4-position was examined. At GluA2(Q) expressed in HEK293 cells (calcium flux experiment), the most potent compound was 11m (4-cyclopropyl-7-(3-methoxyphenoxy)-3,4-dihydro-2H-1,2,4-benzothiadiazine 1,1-dioxide, EC50 = 2.0 nM). The Hill coefficient in the screening and the shape of the dimerization curve in small-angle X-ray scattering (SAXS) experiments using isolated GluA2 ligand-binding domain (GluA2-LBD) are consistent with binding of one molecule of 11m per dimer interface, contrary to most benzothiadiazine dioxides developed to date. This observation was confirmed by the X-ray structure of 11m bound to GluA2-LBD and by NMR. This is the first benzothiadiazine dioxide AMPApam to reach the nanomolar range.Entities:
Mesh:
Substances:
Year: 2017 PMID: 29256599 PMCID: PMC6052356 DOI: 10.1021/acs.jmedchem.7b01323
Source DB: PubMed Journal: J Med Chem ISSN: 0022-2623 Impact factor: 7.446